Blogs Archives - Page 3 of 6 - Wellthy Therapeutics

Category Archives: Blogs

Pharma Checklist for Choosing the Right DTx Partner

The-Ultimate-Guide-to-Choosing-the-Right-Digital-Therapeutics-(DTx)-Partner-v1

If you’ve decided that it’s time to explore the world of Pharma DTx relationships, then you’ll need the right partner. However, with so many different potential DTx partners out there right now, who’s the best fit for your business? Introduction Across healthcare, adoption of digital transformation and technologies has been the norm for almost two

The 6 Simple Steps to Building Great Pharma DTx Partnerships

blog-image1-The-6-Simple-Steps-to-Building-Great-Pharma-DTx-Partnerships

Having partnered with numerous pharma companies around the world, we know a fair bit about building great DTx partnerships at Wellthy. But what makes a truly great partnership? How do you know what to look for in a partner? And what value does it actually drive for pharma? At Wellthy we know what it takes,

Pharma Leader, Karine Soulat joins Wellthy therapeutics as VP Marketing

blog-image

Introducing Karine Soulat, VP Marketing at Wellthy Therapeutics Wellthy Therapeutics is delighted to announce the arrival of Karine Soulat, digital therapeutics and healthcare marketing expert to the senior team. Karine brings a wealth of over 25 years experience working with top ten global pharmaceutical companies Biogen and Bristol Myer-Squibb across global and for European markets.

Pulmonary Hypertension: How Wellthy’s digital tools can improve quality of life

PH-blog-image

Established by the PHA Association, Pulmonary Hypertension Awareness Month is now in its 30th year and encourages those who are connected to the condition to help spread awareness. Co-founder and VP of Partnerships Prayat Shah explains how Wellthy is working with the PH community and how our technology is improving the lives of those living

Wellthy Therapeutics complies to IEC:62304 medical device standard to build and scale robust SaMD solutions

blog-img4

The IEC 62304 standard outlines the life cycle processes, activities, and tasks that are required for the safe design and maintenance of medical device software.1 Adherence to the standard process ensures that necessary actions and precautions have been taken to prevent the risk of an event involving a threat to the life of a patient.

Diabetes: Connecting the Dots for Collaborative Diabetes Care

Diabetes: Connecting the dots for collaborative diabetes care

The theme for this year’s Diabetes Awareness Month is, ‘Access to Diabetes Care: If not now, when?’ urging greater access and care for people living with all types of diabetes. Prayat Shah, Wellthy co-founder and Vice President of Partnerships, explains why type 2 diabetes is an important focus for our team and the wellthy CARE™

The next stage of Pharma-DTx partnerships: what still remains unsolved?

How-taking-a-siloed-approach-towards-Digital-Health-will-cost-BioPharma

The digital health ecosystem has grown at a tremendous pace in the last decade; not only when it comes to technological advancements, but also on patient adoption, traction from life sciences, and the global regulatory and compliance environment front. What began as a tool, limited for academia and technology research, has now shifted into being

How Digital Therapeutics can handhold Healthcare workers to achieve optimal insulin titration

How-Digital-Therapeutics-can-handhold-Healthcare-workers-to-achieve-optimal-insulin-titration

Patients with diabetes may require insulin therapy at a certain point in their journey of living with diabetes. Insulin initiation is recommended when patient’s A1c is ≥7% even after 3 months of triple combination with oral anti-diabetes medicines (OAD) or if patient’s A1c levels are ≥10% (1).  The American Diabetes Association recommends that insulin initiation

How can a DTX intervention reduce hypoglycemic episodes in patients on Insulin?

How-can-a-DTX-intervention-reduce-hypoglycemic-episodes-in-patients-on-Insulin-blog-img

Hypoglycemia episodes are common among patients with diabetes and can vary in severity. The spectrum of these episodes may include: not experiencing any symptoms at all, experiencing sweating, weakness, dizziness to fatal coma, seizures and death. Hypoglycemia is often under-reported and under-diagnosed, despite the fact that it can be disabling and potentially fatal. A study

How to treat Congestive Heart Failure with Virtual Outpatient care via a DTX?

How-to-treat-Congestive-Heart-Failure-with-Virtual-Outpatient-care-via-a-DTX

There is no such thing as a minor cardiac incident. Whether it’s a case of an intermittent angina or anacute discovery of hypertrophic cardiomyopathy – life is never the same afterwards. For millions ofAmericans, life after a cardiac event is often filled with new challenges that fundamentally change everyaspect of their lifestyle. And given recent